CRE research glossary

Review status.

Review status is the state of a field, source, relationship, or opportunity after Acren checks whether it is ready for customer-facing use.

By Acren ResearchUpdated August 27, 2026
Short answer

Review status is the state of a field, source, relationship, or opportunity after Acren checks whether it is ready for customer-facing use.

How Acren uses review status

Review status keeps raw records, weak relationships, incomplete source pulls, and internal-only context out of customer-facing packets until the source rights, display posture, field quality, and confidence labels support display.

Why it matters for CRE acquisition intelligence

Precise language makes an opportunity memo easier to review and harder to overread. The goal is to keep the first screen useful: what the record supports, what is still open, and which diligence step should happen next.

What this does not mean

In Acren, review status does not predict seller intent, transaction intent, a valuation, a rent forecast, NOI, investment advice, or a recommendation to buy, sell, call, or pursue a property. It is part of the research record that helps decide what deserves the next step.

Example

A buyer can use this term to keep the first screen disciplined: identify the property, inspect the source trail, name the open questions, and route the next step.

Common mistakes

  • Using the term as a conclusion instead of a research label.
  • Skipping the next step after the opportunity memo surfaces.
FAQ

Is review status a deal recommendation?

No. It helps explain or route a research lead. Comps, lease research, expenses, broker feedback, legal review, and underwriting remain separate diligence steps.

How should a buyer use this term?

Use it to keep the opportunity memo precise: what the record supports, what is still open, and who should review the next step.

Next step
Start with your market and buy box.

Responsible boundary. Not for FCRA-regulated use. Acren organizes commercial-property and business-entity records and ranks research priority from recorded evidence. It does not predict intent, provide valuation or underwriting, or support consumer-eligibility decisions.